These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

378 related articles for article (PubMed ID: 33119421)

  • 1. Impact of Focal Versus Whole Gland Ablation for Prostate Cancer on Sexual Function and Urinary Continence.
    Borges RC; Tourinho-Barbosa RR; Glina S; Macek P; Mombet A; Sanchez-Salas R; Cathelineau X
    J Urol; 2021 Jan; 205(1):129-136. PubMed ID: 33119421
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Focal prostate cryoablation: initial results show cancer control and potency preservation.
    Bahn DK; Silverman P; Lee F; Badalament R; Bahn ED; Rewcastle JC
    J Endourol; 2006 Sep; 20(9):688-92. PubMed ID: 16999628
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The Effects of Focal Therapy for Prostate Cancer on Sexual Function: A Combined Analysis of Three Prospective Trials.
    Yap T; Ahmed HU; Hindley RG; Guillaumier S; McCartan N; Dickinson L; Emberton M; Minhas S
    Eur Urol; 2016 May; 69(5):844-51. PubMed ID: 26525837
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Propensity Score-Matched Comparison of Partial to Whole-Gland Cryotherapy for Intermediate-Risk Prostate Cancer: An Analysis of the Cryo On-Line Data Registry Data.
    Tay KJ; Polascik TJ; Elshafei A; Tsivian E; Jones JS
    J Endourol; 2017 Jun; 31(6):564-571. PubMed ID: 28385075
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Salvage Local Treatments After Focal Therapy for Prostate Cancer.
    Marra G; Valerio M; Emberton M; Heidenreich A; Crook JM; Bossi A; Pisters LL
    Eur Urol Oncol; 2019 Sep; 2(5):526-538. PubMed ID: 31412013
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Comparison of Outcomes Between Preoperatively Potent Men Treated with Focal Versus Whole Gland Cryotherapy in a Matched Population.
    Mendez MH; Passoni NM; Pow-Sang J; Jones JS; Polascik TJ
    J Endourol; 2015 Oct; 29(10):1193-8. PubMed ID: 26058496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Focal therapy for localised unifocal and multifocal prostate cancer: a prospective development study.
    Ahmed HU; Hindley RG; Dickinson L; Freeman A; Kirkham AP; Sahu M; Scott R; Allen C; Van der Meulen J; Emberton M
    Lancet Oncol; 2012 Jun; 13(6):622-32. PubMed ID: 22512844
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A comparison of time taken to return to baseline erectile function following focal and whole gland ablative therapies for localized prostate cancer: A systematic review.
    Faure Walker NA; Norris JM; Shah TT; Yap T; Cathcart P; Moore CM; Ahmed HU; Emberton M; Minhas S
    Urol Oncol; 2018 Feb; 36(2):67-76. PubMed ID: 29277585
    [TBL] [Abstract][Full Text] [Related]  

  • 9. High Intensity Focused Ultrasound Hemigland Ablation for Prostate Cancer: Initial Outcomes of a United States Series.
    Abreu AL; Peretsman S; Iwata A; Shakir A; Iwata T; Brooks J; Tafuri A; Ashrafi A; Park D; Cacciamani GE; Kaneko M; Duddalwar V; Aron M; Palmer S; Gill IS
    J Urol; 2020 Oct; 204(4):741-747. PubMed ID: 32898975
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Early-Medium-Term Outcomes of Primary Focal Cryotherapy to Treat Nonmetastatic Clinically Significant Prostate Cancer from a Prospective Multicentre Registry.
    Shah TT; Peters M; Eldred-Evans D; Miah S; Yap T; Faure-Walker NA; Hosking-Jervis F; Thomas B; Dudderidge T; Hindley RG; McCracken S; Greene D; Nigam R; Valerio M; Minhas S; Winkler M; Arya M; Ahmed HU
    Eur Urol; 2019 Jul; 76(1):98-105. PubMed ID: 30638633
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Expanded Prostate Cancer Index Composite versus Incontinence Symptom Index and Sexual Health Inventory for Men to measure functional outcomes after prostatectomy.
    Hedgepeth RC; Labo J; Zhang L; Wood DP
    J Urol; 2009 Jul; 182(1):221-7; discussion 227-8. PubMed ID: 19450842
    [TBL] [Abstract][Full Text] [Related]  

  • 12. New and Established Technology in Focal Ablation of the Prostate: A Systematic Review.
    Valerio M; Cerantola Y; Eggener SE; Lepor H; Polascik TJ; Villers A; Emberton M
    Eur Urol; 2017 Jan; 71(1):17-34. PubMed ID: 27595377
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Focal cryosurgical ablation of the prostate: a single institute's perspective.
    Hale Z; Miyake M; Palacios DA; Rosser CJ
    BMC Urol; 2013 Jan; 13():2. PubMed ID: 23311921
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [The role of waterjet dissection in improving erectile function and continence after nerve-sparing prostatectomy].
    Glybochko PV; Alyaev YG; Rapoport LM; Grigorev NA; Bezrukov EA; Tsarichenko DG; Sirota ES; Martirosyan GA
    Urologiia; 2017 Apr; (1):43-49. PubMed ID: 28394522
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Changes in continence and erectile function between 2 and 4 years after radical prostatectomy.
    Glickman L; Godoy G; Lepor H
    J Urol; 2009 Feb; 181(2):731-5. PubMed ID: 19091349
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Extensive Histological Sampling following Focal Therapy of Clinically Significant Prostate Cancer with High Intensity Focused Ultrasound.
    Mortezavi A; Krauter J; Gu A; Sonderer J; Bruhin J; Reeve KA; Held L; Donati OF; Rupp NJ; Moch H; Sulser T; Eberli D
    J Urol; 2019 Oct; 202(4):717-724. PubMed ID: 31042109
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patient Reported Outcome Measures for Transperineal Template Prostate Mapping Biopsies in the PICTURE Study.
    Miah S; Eldred-Evans D; Simmons LAM; Shah TT; Kanthabalan A; Arya M; Winkler M; McCartan N; Freeman A; Punwani S; Moore CM; Emberton M; Ahmed HU
    J Urol; 2018 Dec; 200(6):1235-1240. PubMed ID: 29940251
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Early biochemical recurrence, urinary continence and potency outcomes following robot-assisted radical prostatectomy.
    Berg KD; Thomsen FB; Hvarness H; Christensen IJ; Iversen P
    Scand J Urol; 2014 Aug; 48(4):356-66. PubMed ID: 24579803
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Prospective Multicenter Phase II Study on Focal Therapy (Hemiablation) of the Prostate with High Intensity Focused Ultrasound.
    Ganzer R; Hadaschik B; Pahernik S; Koch D; Baumunk D; Kuru T; Heidenreich A; Stolzenburg JU; Schostak M; Blana A
    J Urol; 2018 Apr; 199(4):983-989. PubMed ID: 29107031
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Magnetic Resonance Imaging-Guided Transurethral Ultrasound Ablation of Prostate Tissue in Patients with Localized Prostate Cancer: A Prospective Phase 1 Clinical Trial.
    Chin JL; Billia M; Relle J; Roethke MC; Popeneciu IV; Kuru TH; Hatiboglu G; Mueller-Wolf MB; Motsch J; Romagnoli C; Kassam Z; Harle CC; Hafron J; Nandalur KR; Chronik BA; Burtnyk M; Schlemmer HP; Pahernik S
    Eur Urol; 2016 Sep; 70(3):447-55. PubMed ID: 26777228
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 19.